MacLeod Stuart
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. Child & Family Research Institute, Vancouver, British Columbia, Canada.
Healthc Manage Forum. 2016 Mar;29(2):87-90. doi: 10.1177/0840470415626524. Epub 2016 Feb 12.
For more than 50 years, the importance of studying new medicines in childhood has been widely recognized. Nonetheless, Health Canada has eschewed policies requiring such evaluation, despite effective reforms elsewhere. In 2012, the Council of Canadian Academies convened an expert panel to assess Canada's research base for labelling of pediatric therapies. The September 2014 report has not yet resulted in action, but it deserves consideration by the new government with timely recognition of the high priority that evidence-based treatment of children deserves.
五十多年来，在儿童群体中研究新型药物的重要性已得到广泛认可。尽管如此，加拿大卫生部仍未采取要求进行此类评估的政策，尽管其他地方已进行了有效改革。2012年，加拿大国家科学院理事会召集了一个专家小组，以评估加拿大儿科治疗药物标签的研究基础。2014年9月的报告尚未促成行动，但新政府应予以考虑，并及时认识到基于证据的儿童治疗应享有高度优先地位。
